Epilepsy Clinical Trials in Los Angeles

Showing 41-60 of 91 trials

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

NCT01002820

This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.

Epilepsy, Complex Partial

Marinus Pharmaceuticals11 participantsStarted Oct 2009

Los Angeles, California, United States • Lexington, Kentucky, United States • Albany, New York, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

NCT00464269

This study will evaluate the efficacy and safety of Brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial onset seizures.

Epilepsy

UCB Pharma400 participantsStarted Sep 2007

Phoenix, Arizona, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +66 more locations

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy Trials in Other Cities

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Study in Pediatric Subjects With Epilepsy

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Does Use of Rapid Response EEG Impact Clinical Decision Making

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Diffusion MRI-1 Imaging Database

Other Conditions in Los Angeles